In Medical Devices, No Exit?
Executive SummaryDespite early hopes, 2000 proved a less than auspicious year for small medical device firms, measured in terms of both IPOs and M&A volume. Acquisitions are still in a trough, particularly compared against the boom year of 1998, and IPO activity this year was lower than expected with a number of the more promising companies hitting problems by year's end.
You may also be interested in...
By merging to create Viatris, Mylan and Pfizer’s Upjohn unit intend to occupy a space between generics players and big pharma by offering a broad array of affordable products all around the world.
Progress is being made towards the implementation of the EU’s new patent system, but the UK’s insistence on severing all ties with the European Court could spell the end for its participation.